Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trialMona Boaz, Manfred S. Green, Zipora Matas et al.|The Lancet|2000Cited by 1k
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsDonald S. Silverberg, Adrian Iaina, Ron Baruch et al.|Journal of the American College of Cardiology|2000Cited by 729
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyDonald S. Silverberg, Adrian Iaina, Dov Wexler et al.|Journal of the American College of Cardiology|2001Cited by 645
Randomised crossover trial of naltrexone in uraemic pruritusGary Peer, Adrian Iaina, Shmuel Kivity et al.|The Lancet|1996Cited by 298
Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three yearsAdrian Iaina, Heschi H. Rotmensch, M Liron et al.|BMJ|1996Cited by 217